Author:
Kitajima Kazuhiro,Doi Hiroshi,Kuribayashi Kozo
Reference36 articles.
1. Tsao AS, Wistuba I, Roth JA, Kindler HL. Malignant pleural mesothelioma. J Clin Oncol. 2009;27:2081–90. https://doi.org/10.1200/JCO.2008.19.8523.
2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology™. Malignant pleural methothelioma updates in Version 2.2018. https://www2.tri-kobe.org/nccn/guideline/lung/english/mpm.pdf.
3. Truong MT, Viswanathan C, Godoy MB, Carter BW, Marom EM. Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations. Semin Roentgenol. 2013;48:323–34. https://doi.org/10.1053/j.ro.2013.03.017.
4. Pass HI, Kranda K, Temeck BK, Feuerstein I, Steinberg SM. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol. 1997;4:215–22. https://doi.org/10.1007/bf02306613.
5. Boutin C, Rey F, Gouvernet J, Viallat JR, Astoul P, Ledoray V. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: prognosis and staging. Cancer. 1993;72:394–404. https://doi.org/10.1002/1097-0142(19930715)72:2<394::aid-cncr2820720214>3.0.co;2-5.